(NEXSTAR) – A federal panel of experts that voted against Pfizer booster shots for all Americans unanimously supported a third vaccine injection for people at higher risk from the virus. All 18 ...

The next round of Covid booster shots should be modified to target the supercontagious omicron variant, a Food and Drug Administration advisory committee recommended on Tuesday. The vote capped off a ...

On Tuesday, an advisory panel of the Food and Drug Administration met to discuss what the next generation of COVID-19 boosters might look like this fall. And Thursday the panel agreed they should ...

A panel advising the Centers for Disease Control and Prevention voted 13–1 to recommend Covid vaccine boosters for children ages 12–15 on Wednesday. The panel, known as the Advisory Committee on ...

While FDA is expected to embrace the panel's recommendation, further booster shots may be advised on a regular basis in the future A panel of independent experts is recommending that the Food and Drug ...

A Food and Drug Administration (FDA) advisory panel voted 18-0 to authorize a Pfizer booster shot for Americans 65 years and older and those at risk of severe COVID-19 infection. The panel also voted ...

Ilana Diener holds her son, Hudson, 3, during an appointment for a Moderna Covid-19 vaccine trial in Commack, N.Y., on Nov. 30, 2021. (AP Photo/Emma H. Tobin) (CN) — No vote was taken in a meeting of ...

A key advisory panel to the Centers for Disease Control and Prevention (CDC) voted Thursday to endorse the administration of Pfizer’s COVID-19 booster shots to those 65 and older, nursing home ...

An influential federal advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots to most Americans, but it endorsed the extra shots for those who are 65 or older or ...

A key independent Food and Drug Administration (FDA) panel has endorsed booster shots of Moderna’s COVID-19 vaccine for certain groups of Americans. The advisers to the FDA voted Thursday to recommend ...

The FDA and CDC are ironing out the details of who gets one and when. An advisory panel for the Food and Drug Administration weighed in on a debate Friday that has been boiling since the Biden ...